1. Montelukast suppresses the development of irritable bowel syndrome phenotype possibly through modulating NF-κB signaling in an experimental model
   Pariya Khodabakhsh et al, 2022, Inflammopharmacology CrossRef
2. Montelukast induces beneficial behavioral outcomes and reduces inflammation in male and female rats
   Ira S. Rostevanov et al, 2022, Frontiers in Immunology CrossRef
3. Cognitive, Emotional, and Behavioral Disorders in Children with Respiratory Allergic Diseases: Causes and Solutions
   Natalia V. Ustinova et al, 2024, Pediatric pharmacology CrossRef
4. The Prophylactic Effects of Isosteviol Aerosol Inhalation on Bronchial Asthma in Mice
   Haihua Guo et al, 2024, Pharmaceutical Chemistry Journal CrossRef